Philips Healthcare announced today that it has integrated Masimo's rainbow SET technology into its IntelliVue patient monitoring platform. The company plans to also integrate it with its Philips SureSigns and Philips Efficia patient monitoring platforms in the near future.
With the rainbow SET technology, the IntelliVue platform can now noninvasively and continually measure total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and Pleth Variability Index (PVI).
SpHb measures total hemoglobin in the patient's blood and provides the clinician with real-time data on changes or lack of changes in hemoglobin in the time between invasive blood samples.
PVI measures dynamic changes in Perfusion Index that takes place during one or more complete respiratory cycles. It might also show changes that are associated with physiologic factors such as vascular tone, circulating blood volume and intrathoracic pressure excursions.
Philips' patient monitoring platforms also allow for SpO2 pulse oximetry measurement with its Philips FAST SpO2 pulse oximetry and Covidien's OxiMax SpO2 pulse oximetry.
In the May issue of HCB News magazine our trend report on patient monitors looks at a new parameter that is gaining interest. Two or three years ago, end tidal CO2 was perceived as something nice to measure, but now it is becoming a standard, just like pulse oximetry, blood pressure, and temperature.
In other news, Masimo announced today that a university hospital in France, Centre Hospitalier Universitaire de Limoges, has installed its Radical-7 including SpHb, PVI and SET pulse oximetry technology to monitor surgical patients and patients in the post-anesthesia care unit and ICU.
For three years, the university tested SpHB and PVI on every surgical patient in its facility and then compared that data to the previous period without the technology, and they found that it lead to a notable reduction in mortality in surgeries lasting longer than two hours and among patients over 60 years old.
